Back
Intellia Therapeutics Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
37
NTLA
Intellia Therapeutics
Last Price:
$9.60
Seasonality Move:
19.08%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaIntellia Therapeutics Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 22.4% based on the past 9 years of stock performance.
-
Intellia Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Intellia Therapeutics Stock Undervalued?The current Intellia Therapeutics [NTLA] share price is $9.60. The Score for NTLA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 22.4% based on the past 9 years of stock performance.
Intellia Therapeutics Stock Rating
Sell
37
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics overpriced?
-
Intellia Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Intellia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.18
52-Week Low:
5.90
Prediction Charts
Market Cap:
994.4M
Price in USD:
9.60
Volume:
5.8M
Beta:
1.99
Technical Analysis
SMA50:
8.18
SMA100:
8.87
SMA200:
12.60
52-Wk Change:
-61.29%
Stock Predictions
-
Is Intellia Therapeutics stock public?Yes, Intellia Therapeutics is a publicly traded company.
-
What is the Intellia Therapeutics stock quote today?The Intellia Therapeutics stock price is 9.60 USD today.
-
How to buy Intellia Therapeutics stock online?You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-30 | 7.43 | 6.87 | 7.43 | 6.83 |
| Jun-2 | 6.93 | 7.16 | 7.59 | 6.92 |
| Jun-3 | 7.27 | 7.69 | 7.76 | 6.98 |
| Jun-4 | 7.66 | 7.67 | 7.84 | 7.52 |
| Jun-5 | 7.63 | 7.58 | 7.88 | 7.31 |
| Jun-6 | 7.79 | 8.09 | 8.40 | 7.75 |
| Jun-9 | 8.38 | 8.28 | 8.77 | 8.00 |
| Jun-10 | 8.42 | 8.47 | 9.13 | 8.36 |
| Jun-11 | 8.66 | 8.37 | 8.69 | 8.22 |
| Jun-12 | 8.20 | 8.35 | 8.45 | 8.06 |
| Jun-13 | 8.02 | 8.31 | 8.48 | 8.00 |
| Jun-16 | 8.54 | 8.96 | 9.11 | 8.25 |
| Jun-17 | 10.03 | 9.58 | 10.52 | 9.53 |
| Jun-18 | 9.61 | 9.60 | 9.71 | 9.01 |
Intellia Therapeutics Earnings
Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics Forecast Revenue Growth
Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.12 per share, and an increase next year of $0.30 per share.
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.